A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer Meeting Abstract


Authors: O'Reilly, E.; Hammond, L.; Donehower, R.; Schwartz, G.; Kelvin, J.; Aird, S.; Sharma, S.; Schrag, D.; Molloy, K.; De Jager, R.
Abstract Title: A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer
Meeting Title: 25th European Society of Medical Oncology (ESMO) Congress
Journal Title: Annals of Oncology
Volume: 11
Issue: Suppl. 4
Meeting Dates: 2000 Oct 13-17
Meeting Location: Hamburg, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2000-01-01
Start Page: 63
Language: English
ACCESSION: WOS:000089503900278
PROVIDER: wos
PUBMED: 11077566
DOI: 10.1093/annonc/11.suppl_4.62
Notes: Meeting Abstract: 277O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Sunil Sharma
    26 Sharma
  3. Deborah Schrag
    229 Schrag
  4. Eileen O'Reilly
    783 O'Reilly
  5. Joanne F Kelvin
    92 Kelvin
  6. Suzan M Aird
    3 Aird